Agios Pharmaceuticals Inc. (AGIO)

47.14
2.20 4.40
NASDAQ : Health Technology
Prev Close 49.30
Open 49.42
Day Low/High 47.12 / 49.42
52 Wk Low/High 41.63 / 94.39
Volume 230.97K
Avg Volume 560.50K
Exchange NASDAQ
Shares Outstanding 58.71M
Market Cap 2.85B
EPS -6.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

(Graphic: Business Wire)

(Graphic: Business Wire)

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

TheStreet Quant Rating: D (Sell)